These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 36555792)

  • 61. Recent advances on pathogenesis and therapies in systemic sclerosis.
    Yazawa N; Fujimoto M; Tamaki K
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):107-12. PubMed ID: 18064573
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.
    Xu X; Ramanujam M; Visvanathan S; Assassi S; Liu Z; Li L
    PLoS One; 2020; 15(11):e0242863. PubMed ID: 33253326
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The contemporary management of systemic sclerosis.
    Eldoma M; Pope J
    Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systemic sclerosis: a prototypic multisystem fibrotic disorder.
    Varga J; Abraham D
    J Clin Invest; 2007 Mar; 117(3):557-67. PubMed ID: 17332883
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of B cells in the development of systemic sclerosis.
    Yoshizaki A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Sato S
    Front Immunol; 2022; 13():938785. PubMed ID: 35967355
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gastrointestinal tract microbiota modifications in systemic sclerosis.
    Volkmann ER; Hoffmann-Vold AM
    Eur J Rheumatol; 2020 Oct; 7(Suppl 3):S228-S236. PubMed ID: 31922474
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease.
    Streicher K; Sridhar S; Kuziora M; Morehouse CA; Higgs BW; Sebastian Y; Groves CJ; Pilataxi F; Brohawn PZ; Herbst R; Ranade K
    Arthritis Rheumatol; 2018 Dec; 70(12):2087-2095. PubMed ID: 29956883
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
    Shen C; Jiang Y; Li Q; Liu C; Hu F; Li M
    J Dermatol Sci; 2021 Aug; 103(2):82-92. PubMed ID: 34266726
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial.
    Hoffmann-Vold AM; Fretheim HH; Sarna VK; Barua I; Carstens MN; Distler O; Khanna D; Volkmann ER; Midtvedt Ø; Didriksen H; Dhainaut A; Halse AK; Bakland G; Pesonen M; Olsen I; Molberg Ø
    BMJ Open; 2021 Jun; 11(6):e048541. PubMed ID: 34168032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emerging drugs and therapeutics for systemic sclerosis.
    Lee JJ; Pope JE
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):421-430. PubMed ID: 27813423
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
    Asano Y; Takahashi T; Saigusa R
    J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications.
    Lescoat A; Lecureur V; Varga J
    Curr Opin Rheumatol; 2021 Nov; 33(6):463-470. PubMed ID: 34506339
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of psoriasis with ustekinumab improved skin tightening in systemic sclerosis.
    Ichihara A; Jinnin M; Ihn H
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):208-210. PubMed ID: 28422002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.
    Liu J; Pi Z; Xiao Y; Zeng Z; Yu J; Zou P; Tang B; Qiu X; Tang R; Shi Y; Xiao R
    Pharmacol Res; 2022 Feb; 176():106057. PubMed ID: 34995795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies.
    Asano Y; Varga J
    Semin Cell Dev Biol; 2020 May; 101():146-160. PubMed ID: 31859147
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
    Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
    Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.